GENETWORx, a clinical diagnostics laboratory, has announced its plans to acquire or partner with other diagnostics laboratories to scale a national platform. The laboratory specializes in molecular pathogen and pharmacogenomic testing, providing accurate and timely information to healthcare providers for proper prescription and improved patient outcomes. GENETWORx uses molecular PCR pathogen testing to generate more accurate results than standard culture and sensitivity testing, providing clear and concise reports that identify the type and percentage of pathogens causing an infection and antimicrobial resistance. The laboratory also offers pharmacogenomic (PGx) testing, which detects genetic differences that affect the metabolism of therapeutic medications, providing clinicians with insights to improve therapeutic efficacy, reduce adverse effects, and modify therapy in certain circumstances. The partnership with other laboratories will expand accessibility to patients and improve patient outcomes.
GENETWORx, a private equity backed laboratory, announces it’s looking to buy or partner with other diagnostics laboratories.
GENETWORx is a clinical diagnostics laboratory based outside of Richmond, VA, that specializes in molecular pathogen and pharmacogenomic testing. GENETWORx offers providers the information they needed to properly prescribe therapeutic options, resulting in improved outcomes.
“We are looking to acquire or strategically partner with laboratories to scale a national platform,” says Steve Crossley, CEO for GENETWORx. “As we look to the future of diagnostic testing, partnering with other laboratories will expand accessibility to patients and, ultimately, improve patient outcomes. We’re excited to be a part of leading the future of diagnostic testing together.”
Molecular Pathogen Testing
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Molecular PCR pathogen testing generates results that are more accurate than standard culture and sensitivity testing within 24-48 hours of lab receipt. GENETWORx offers clear and concise reports that provide a picture of the type and percent of pathogens causing an infection and, in many cases, identifies antimicrobial resistance regardless of concurrent antibiotic use.
Pharmacogenomic Testing
Pharmacogenomic (PGx) testing is a DNA Medication-Response test that detects genetic differences that affect the metabolism of therapeutic medications and possibilities for adverse events. PGX testing provides pertinent information to ensure patients are prescribed the most effective medication based on drug-metabolism pathways. Understanding how patients metabolize medications and gene/drug interactions may help clinicians improve therapeutic efficacy and reduce adverse effects, while providing insight into potential therapy modifications in certain circumstances.
Source: BioSpace